Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Raises Price Target to $226
Portfolio Pulse from Benzinga Newsdesk
Keefe, Bruyette & Woods analyst Kyle Voigt maintains a Market Perform rating on CME Group (NASDAQ:CME) and raises the price target from $222 to $226.
April 25, 2024 | 1:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keefe, Bruyette & Woods maintains a Market Perform rating on CME Group and raises the price target from $222 to $226.
The increase in price target by Keefe, Bruyette & Woods suggests a positive outlook on CME Group's future performance, potentially leading to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100